Gum Tech (GUMM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gum Tech (GUMM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bengalus who wrote (92)	1/29/1999 11:43:00 AM
From: Street Walker	Read Replies (3) of 133

Zinulose is not Coldeeze ----- Future Financials I can tell you are not a scientist, nor someone who can analyze forward looking fundamentals. You are looking at past financials. This is a new product. Can't you do Forward looking Fincancials? You are also Short and there are more LONGS than Shorts. You have a big battle on your hands in the long term. from yahoo: How __BIG___is__ZICAM ? ___answer >>>>>>>We can no longer look at GUMM FUNDAMENTALS historically. Their financials and Market Cap need to be viewed with PROJECTIONS of the future, based on ZICAM. Common Colds is a huge industry. Its an extremely lucrative industy. There are 1 Billion Colds in the US. ZICAM is the VERY BEST PRODUCT for this industry. This is a proprietary product. zicam.com [info from a local pharmacist] ZICAM costs the consumer around $12.50 He said the standard mark-up is 100% So the store is buying it from GUMM at around $6. Profit margins on solution type products are between 70%-85% Lets assume 70% profit margin -conservative- that means GUMM makes about $4 per sale ! GUMM will be rolling in the money. <<<<<< * * sw

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next